Boston Scientific Corp. (BSX) News
Filter BSX News Items
BSX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BSX News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest BSX News From Around the Web
Below are the latest news stories about BOSTON SCIENTIFIC CORP that investors may wish to consider to help them evaluate BSX as an investment opportunity.
How to Find Strong Medical Stocks Slated for Positive Earnings SurprisesInvestors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP. |
Here's Why You Should Retain HealthEquity Stock in Your Portfolio NowHQY's sustained strength in HSAs raises optimism about the stock. |
Reasons to Retain The Cooper Companies Stock in Your Portfolio NowCOO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning. |
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin DeclinesANGO registers overall strong top-line results on a pro-forma basis in second-quarter fiscal 2025, driven by strength in the Med Tech business. |
J&J Pauses Sales of Atrial Fibrillation Device, Stock DownJ&J's MedTech unit pauses all cases of the Varipulse PFA system as part of an external evaluation. Stock dips. |
BSX Stock Rises Following Bolt Medical Acquisition Deal AnnouncementBoston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million. |
Here's Why You Should Add Glaukos Stock to Your Portfolio NowGKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism. |
Are Boston Scientific Corporation (NYSE:BSX) Investors Paying Above The Intrinsic Value?Key Insights The projected fair value for Boston Scientific is US$75.65 based on 2 Stage Free Cash Flow to Equity... |
5 medtech trends to watch in 2025After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year. |
Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664mBolt Medical has developed an intravascular lithotripsy laser-based platform. |